LBA20TRIBE2: A phase III, randomized strategy study by GONO in the 1st- and 2nd-line treatment of unresectable metastatic colorectal cancer (mCRC) patients (pts). (23rd October 2018) - Cremolini, C; Antoniotti, C; Lonardi, S; Rossini, D; Pietrantonio, F; Cordio, S S; Murgioni, S; Marmorino, F; Maiello, E; Passardi, A; Masi, G; Tamburini, E; et al.